Withdrawal Notice: Hydroxyethylstarch Linked to Increased Risk of Acute Kidney Injury
Overview
The article has been retracted due to concerns regarding ethical approval and data reliability.
Background
Hydroxyethyl starch (HES) has been widely used in various clinical scenarios to treat hypovolemia. Recent regulatory actions and studies have raised concerns about the safety of HES, particularly regarding acute kidney injury (AKI) associated with its use.
Data Highlights
No numerical data is available due to the retraction of the article.
Key Findings
The article has been retracted due to ethical and data concerns.
Regulatory bodies, including the EMA and FDA, have issued warnings regarding the use of HES.
Guidelines recommend against the use of HES in patients with sepsis or septic shock.
Clinical Implications
Healthcare professionals should be aware of the retraction and the associated risks of HES.
Conclusion
The article has been retracted due to concerns regarding ethical approval and data reliability.
